FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
HIMCX
Price
$22.67
Change
+$0.15 (+0.67%)
Updated
Aug 21 closing price
Net Assets
690.59M
Interact to see
Advertisement

FSMAX vs HIMCX

FSMAX vs HIMCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. HIMCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and HIMCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. HIMCX (691M). FSMAX pays higher dividends than HIMCX: FSMAX (0.50) vs HIMCX (0.00). FSMAX was incepted earlier than HIMCX: FSMAX (15 years) vs HIMCX (29 years). HIMCX (0.76) is less costly to investors than FSMAX (0.04). HIMCX is a more actively managed with annual turnover of: 60.00 vs. FSMAX (23.00). FSMAX (0) and HIMCX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. HIMCX (-22.39). FSMAX return over 5 years is better than : 40.14 vs. HIMCX (-50.27).
FSMAXHIMCXFSMAX / HIMCX
Total Expense Ratio0.040.765%
Annual Report Gross Expense Ratio0.040.765%
Fund Existence15 years29 years-
Gain YTD16.937-2.284-741%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B691M5,803%
Annual Yield % from dividends0.500.00-
Returns for 1 year23.68-22.39-106%
Returns for 3 years72.74-15.72-463%
Returns for 5 years40.14-50.27-80%
Returns for 10 years134.49-36.21-371%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSLLX23.010.26
+1.14%
Morgan Stanley Inst Passport ovrs eq L
GVIZX15.640.08
+0.51%
GuideStone Funds Value Equity Index Inv
PKSFX52.810.22
+0.42%
Virtus KAR Small-Cap Core I
FTDWX14.75N/A
N/A
Fidelity Advisor Asset Manager 20% M
MSVVX5.70N/A
N/A
MetLife Small Company Equity Investor